SMO and skin basal cell carcinoma: In human, mutations in Hh major components (PTCH1, SMO) are associated with sporadic and familial skin cancers (basal cell carcinoma, BCC), brain tumors (medulloblastoma, MB) and rhabdomyosarcoma (RMS) [3, 4].